APO Research
Talk to an analyst

APO RESEARCH · REPORT

Humira

Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.

Humira is used to treat many inflammatory conditions in adults, such as ulcerative colitis, Rheumatoid Arthritis, psoriatic arthritis, Ankylosing Spondylitis, plaque psoriasis, and a skin condition called hidradenitis suppurativa.

Humira is also used in adults and children to treat Crohn's disease or juvenile idiopathic arthritis.

In 2014, in India, the first adalimumab biosimilar came to market at a price of $200. Two years later, another Indian drugmaker, Torrent Pharmaceuticals, launched a second biosimilar. Humira's U.S. patent expired in 2016.

Selected research

Industry Growth & Trends

Global Humira Industry Growth and Trends Forecast to 2032

23 December 202597 pages

Choose your research edition.

Industry ResearchHumira Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Humira Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Humira Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Humira Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Humira Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.

Humira is used to treat many inflammatory conditions in adults, such as ulcerative colitis, Rheumatoid Arthritis, psoriatic arthritis, Ankylosing Spondylitis, plaque psoriasis, and a skin condition called hidradenitis suppurativa.

Humira is also used in adults and children to treat Crohn's disease or juvenile idiopathic arthritis.

Read the full market overview

In 2014, in India, the first adalimumab biosimilar came to market at a price of $200. Two years later, another Indian drugmaker, Torrent Pharmaceuticals, launched a second biosimilar. Humira's U.S. patent expired in 2016.

The classification of Humira includes Humira Syringe and Humira Pen. The proportion of Humira Syringe is about 78%.

Humira is widely used for Ankylosing Spondylitis, Rheumatoid Arthritis, Crohn’s disease and other disease. The most proportion of Humira is for Ankylosing Spondylitis, and the proportion is about 43%.

USA is the largest market, with a sales market share nearly 65%. Following USA, Europe is the second largest market with the sales market share of 30%.

Market competition will intense. AbbVie, Eisai, Cadila Healthcare, Torrent Pharmaceuticals, Amgen and Boehringer Ingelheim are the key manufacturters of Humira. AbbVie is the leader of this industry by 97% market shares.

Report Scope

This report provides a structured, data-driven view of the global Humira market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Humira market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Humira market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Humira.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Humira market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Humira Market by Company

AbbVie

Eisai

Cadila Healthcare

Torrent Pharmaceuticals

Amgen

Boehringer Ingelheim

Humira Segment by Type

Humira Syringe

Humira Pen

Humira Segment by Application

Ankylosing Spondylitis

Rheumatoid Arthritis

Crohn’s Disease

Others

Humira Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Humira market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Humira and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Humira.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Humira manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Humira in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Humira Syringe Table 2. Major Company of Humira Pen Table 3. Global Humira Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Humira Sales by Type (2021-2026) & (K Units) Table 5. Global Humira Sales Market Share in Volume by Type (2021-2026) Table 6. Global Humira Sales by Type (2021-2026) & (US$ Million) Table 7. Global Humira Sales Market Share in Value by Type (2021-2026) Table 8. Global Humira Price by Type (2021-2026) & (USD/Unit) Table 9. Global Humira Sales by Type (2027-2032) & (K Units) Table 10. Global Humira Sales Market Share in Volume by Type (2027-2032) Table 11. Global Humira Sales by Type (2027-2032) & (US$ Million) Table 12. Global Humira Sales Market Share in Value by Type (2027-2032) Table 13. Global Humira Price by Type (2027-2032) & (USD/Unit) Table 14. North America Humira Sales by Type (2021-2026) & (K Units) Table 15. North America Humira Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Humira Sales by Type (2021-2026) & (K Units) Table 17. Europe Humira Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Humira Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Humira Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Humira Sales by Type (2021-2026) & (K Units) Table 21. Latin America Humira Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Humira Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Humira Sales by Type (2021-2026) & (US$ Million) Table 24. Humira Industry Trends Table 25. Humira Industry Drivers Table 26. Humira Industry Opportunities and Challenges Table 27. Humira Industry Restraints Table 28. Global Humira Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Humira Revenue Market Share by Company (2021-2026) Table 30. Global Humira Sales by Company (2021-2026) & (K Units) Table 31. Global Humira Sales Share by Company (2021-2026) Table 32. Global Humira Market Price by Company (2021-2026) & (USD/Unit) Table 33. Global Humira Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Humira Major Company Production Sites and Headquarters Table 35. Global Humira Company, Product Type & Application Table 36. Global Humira Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Humira by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Humira Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Humira Sales by Region (2021-2026) & (K Units) Table 41. Global Humira Sales Market Share in Volume by Region (2021-2026) Table 42. Global Humira Sales by Region (2021-2026) & (US$ Million) Table 43. Global Humira Sales Market Share in Value by Region (2021-2026) Table 44. Global Humira Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 45. Global Humira Sales by Region (2027-2032) & (K Units) Table 46. Global Humira Sales Market Share in Volume by Region (2027-2032) Table 47. Global Humira Sales by Region (2027-2032) & (US$ Million) Table 48. Global Humira Sales Market Share in Value by Region (2027-2032) Table 49. Global Humira Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 50. Global Humira Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Humira Sales by Application (2021-2026) & (K Units) Table 52. Global Humira Sales Market Share in Volume by Application (2021-2026) Table 53. Global Humira Sales by Application (2021-2026) & (US$ Million) Table 54. Global Humira Sales Market Share in Value by Application (2021-2026) Table 55. Global Humira Price by Application (2021-2026) & (USD/Unit) Table 56. Global Humira Sales by Application (2027-2032) & (K Units) Table 57. Global Humira Sales Market Share in Volume by Application (2027-2032) Table 58. Global Humira Sales by Application (2027-2032) & (US$ Million) Table 59. Global Humira Sales Market Share in Value by Application (2027-2032) Table 60. Global Humira Price by Application (2027-2032) & (USD/Unit) Table 61. North America Humira Sales by Application (2021-2026) & (K Units) Table 62. North America Humira Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Humira Sales by Application (2021-2026) & (K Units) Table 64. Europe Humira Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Humira Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Humira Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Humira Sales by Application (2021-2026) & (K Units) Table 68. Latin America Humira Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Humira Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Humira Sales by Application (2021-2026) & (US$ Million) Table 71. AbbVie Company Information Table 72. AbbVie Business Overview Table 73. AbbVie Humira Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. AbbVie Humira Product Portfolio Table 75. AbbVie Recent Development Table 76. Eisai Company Information Table 77. Eisai Business Overview Table 78. Eisai Humira Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. Eisai Humira Product Portfolio Table 80. Eisai Recent Development Table 81. Cadila Healthcare Company Information Table 82. Cadila Healthcare Business Overview Table 83. Cadila Healthcare Humira Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. Cadila Healthcare Humira Product Portfolio Table 85. Cadila Healthcare Recent Development Table 86. Torrent Pharmaceuticals Company Information Table 87. Torrent Pharmaceuticals Business Overview Table 88. Torrent Pharmaceuticals Humira Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. Torrent Pharmaceuticals Humira Product Portfolio Table 90. Torrent Pharmaceuticals Recent Development Table 91. Amgen Company Information Table 92. Amgen Business Overview Table 93. Amgen Humira Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Amgen Humira Product Portfolio Table 95. Amgen Recent Development Table 96. Boehringer Ingelheim Company Information Table 97. Boehringer Ingelheim Business Overview Table 98. Boehringer Ingelheim Humira Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. Boehringer Ingelheim Humira Product Portfolio Table 100. Boehringer Ingelheim Recent Development Table 101. North America Humira Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. North America Humira Sales by Country (2021-2026) & (K Units) Table 103. North America Humira Sales Market Share by Country (2021-2026) Table 104. North America Humira Sales Forecast by Country (2027-2032) & (K Units) Table 105. North America Humira Sales Market Share Forecast by Country (2027-2032) Table 106. North America Humira Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Humira Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Humira Market Share by Country (2021-2026) Table 109. North America Humira Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Humira Market Share Forecast by Country (2027-2032) Table 111. Europe Humira Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Europe Humira Sales by Country (2021-2026) & (K Units) Table 113. Europe Humira Sales Market Share by Country (2021-2026) Table 114. Europe Humira Sales Forecast by Country (2027-2032) & (K Units) Table 115. Europe Humira Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Humira Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Humira Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Humira Market Share by Country (2021-2026) Table 119. Europe Humira Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Humira Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Humira Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Humira Sales by Country (2021-2026) & (K Units) Table 123. Asia-Pacific Humira Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Humira Sales Forecast by Country (2027-2032) & (K Units) Table 125. Asia-Pacific Humira Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Humira Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Humira Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Humira Market Share by Country (2021-2026) Table 129. Asia-Pacific Humira Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Humira Market Share Forecast by Country (2027-2032) Table 131. Latin America Humira Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Latin America Humira Sales by Country (2021-2026) & (K Units) Table 133. Latin America Humira Sales Market Share by Country (2021-2026) Table 134. Latin America Humira Sales Forecast by Country (2027-2032) & (K Units) Table 135. Latin America Humira Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Humira Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Humira Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Humira Market Share by Country (2021-2026) Table 139. Latin America Humira Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Humira Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Humira Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Humira Sales by Country (2021-2026) & (K Units) Table 143. Middle East and Africa Humira Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Humira Sales Forecast by Country (2027-2032) & (K Units) Table 145. Middle East and Africa Humira Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Humira Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Humira Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Humira Market Share by Country (2021-2026) Table 149. Middle East and Africa Humira Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Humira Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Humira Distributors List Table 154. Humira Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Humira Image Figure 2. Global Humira Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Humira Market Size (2021-2032) & (US$ Million) Figure 4. Global Humira Sales (2021-2032) & (K Units) Figure 5. Humira Syringe Image Figure 6. Global Humira Syringe Sales YoY Growth (2021-2032) & (K Units) Figure 7. Humira Pen Image Figure 8. Global Humira Pen Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Humira Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Humira Market Share by Type 2025 VS 2032 Figure 11. North America Humira Sales Market Share in Volume by Type in 2025 Figure 12. North America Humira Sales Market Share in Value by Type in 2025 Figure 13. Europe Humira Sales Market Share in Volume by Type in 2025 Figure 14. Europe Humira Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Humira Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Humira Sales Market Share in Value by Type in 2025 Figure 17. Latin America Humira Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Humira Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Humira Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Humira Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Humira Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Ankylosing Spondylitis Image Figure 24. Global Ankylosing Spondylitis Sales YoY Growth (2021-2032) & (K Units) Figure 25. Rheumatoid Arthritis Image Figure 26. Global Rheumatoid Arthritis Sales YoY Growth (2021-2032) & (K Units) Figure 27. Crohn’s Disease Image Figure 28. Global Crohn’s Disease Sales YoY Growth (2021-2032) & (K Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Humira Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Humira Market Share by Application 2025 VS 2032 Figure 33. North America Humira Sales Market Share in Volume by Application in 2025 Figure 34. North America Humira Sales Market Share in Value by Application in 2025 Figure 35. Europe Humira Sales Market Share in Volume by Application in 2025 Figure 36. Europe Humira Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Humira Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Humira Sales Market Share in Value by Application in 2025 Figure 39. Latin America Humira Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Humira Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Humira Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Humira Sales Market Share in Value by Application in 2025 Figure 43. North America Humira Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Humira Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Humira Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Humira Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Humira Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Humira Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Humira Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Humira Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Humira Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Humira Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Humira Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Humira Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Humira Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Humira Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Humira Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Humira Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Humira Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Humira Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Humira Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Humira Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Humira Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Humira Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Humira Syringe
  • Humira Pen
Applications
  • Ankylosing Spondylitis
  • Rheumatoid Arthritis
  • Crohn’s Disease
  • Others
Companies covered
  • AbbVie
  • Eisai
  • Cadila Healthcare
  • Torrent Pharmaceuticals
  • Amgen
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Humira Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Humira Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Humira Market by Type
  6. 1.3.1 Humira Syringe
  7. 1.3.2 Humira Pen
  8. 1.4 Global Humira Market Size by Type
  9. 1.4.1 Global Humira Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Humira Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Humira Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Humira Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Humira Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Humira Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Humira Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Humira Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Humira Industry Trends
  2. 2.2 Humira Industry Drivers
  3. 2.3 Humira Industry Opportunities and Challenges
  4. 2.4 Humira Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Humira Revenue (2021-2026)
  2. 3.2 Global Top Players by Humira Sales (2021-2026)
  3. 3.3 Global Top Players by Humira Price (2021-2026)
  4. 3.4 Global Humira Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Humira Major Company Production Sites & Headquarters
  6. 3.6 Global Humira Company, Product Type & Application
  7. 3.7 Global Humira Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Humira Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Humira Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Humira Tier 1, Tier 2, and Tier 3
4 Humira Regional Status and Outlook
  1. 4.1 Global Humira Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Humira Historic Market Size by Region
  3. 4.2.1 Global Humira Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Humira Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Humira Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Humira Forecasted Market Size by Region
  7. 4.3.1 Global Humira Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Humira Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Humira Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Humira by Application
  1. 5.1 Humira Market by Application
  2. 5.1.1 Ankylosing Spondylitis
  3. 5.1.2 Rheumatoid Arthritis
  4. 5.1.3 Crohn’s Disease
  5. 5.1.4 Others
  6. 5.2 Global Humira Market Size by Application
  7. 5.2.1 Global Humira Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Humira Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Humira Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Humira Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Humira Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Humira Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Humira Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Humira Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AbbVie
  2. 6.1.1 AbbVie Company Information
  3. 6.1.2 AbbVie Business Overview
  4. 6.1.3 AbbVie Humira Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AbbVie Humira Product Portfolio
  6. 6.1.5 AbbVie Recent Developments
  7. 6.2 Eisai
  8. 6.2.1 Eisai Company Information
  9. 6.2.2 Eisai Business Overview
  10. 6.2.3 Eisai Humira Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Eisai Humira Product Portfolio
  12. 6.2.5 Eisai Recent Developments
  13. 6.3 Cadila Healthcare
  14. 6.3.1 Cadila Healthcare Company Information
  15. 6.3.2 Cadila Healthcare Business Overview
  16. 6.3.3 Cadila Healthcare Humira Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Cadila Healthcare Humira Product Portfolio
  18. 6.3.5 Cadila Healthcare Recent Developments
  19. 6.4 Torrent Pharmaceuticals
  20. 6.4.1 Torrent Pharmaceuticals Company Information
  21. 6.4.2 Torrent Pharmaceuticals Business Overview
  22. 6.4.3 Torrent Pharmaceuticals Humira Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Torrent Pharmaceuticals Humira Product Portfolio
  24. 6.4.5 Torrent Pharmaceuticals Recent Developments
  25. 6.5 Amgen
  26. 6.5.1 Amgen Company Information
  27. 6.5.2 Amgen Business Overview
  28. 6.5.3 Amgen Humira Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Amgen Humira Product Portfolio
  30. 6.5.5 Amgen Recent Developments
  31. 6.6 Boehringer Ingelheim
  32. 6.6.1 Boehringer Ingelheim Company Information
  33. 6.6.2 Boehringer Ingelheim Business Overview
  34. 6.6.3 Boehringer Ingelheim Humira Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Boehringer Ingelheim Humira Product Portfolio
  36. 6.6.5 Boehringer Ingelheim Recent Developments
7 North America by Country
  1. 7.1 North America Humira Sales by Country
  2. 7.1.1 North America Humira Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Humira Sales by Country (2021-2026)
  4. 7.1.3 North America Humira Sales Forecast by Country (2027-2032)
  5. 7.2 North America Humira Market Size by Country
  6. 7.2.1 North America Humira Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Humira Market Size by Country (2021-2026)
  8. 7.2.3 North America Humira Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Humira Sales by Country
  2. 8.1.1 Europe Humira Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Humira Sales by Country (2021-2026)
  4. 8.1.3 Europe Humira Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Humira Market Size by Country
  6. 8.2.1 Europe Humira Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Humira Market Size by Country (2021-2026)
  8. 8.2.3 Europe Humira Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Humira Sales by Country
  2. 9.1.1 Asia-Pacific Humira Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Humira Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Humira Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Humira Market Size by Country
  6. 9.2.1 Asia-Pacific Humira Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Humira Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Humira Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Humira Sales by Country
  2. 10.1.1 South America Humira Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Humira Sales by Country (2021-2026)
  4. 10.1.3 South America Humira Sales Forecast by Country (2027-2032)
  5. 10.2 South America Humira Market Size by Country
  6. 10.2.1 South America Humira Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Humira Market Size by Country (2021-2026)
  8. 10.2.3 South America Humira Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Humira Sales by Country
  2. 11.1.1 Middle East and Africa Humira Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Humira Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Humira Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Humira Market Size by Country
  6. 11.2.1 Middle East and Africa Humira Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Humira Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Humira Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Humira Value Chain Analysis
  2. 12.1.1 Humira Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Humira Production Mode & Process
  7. 12.2 Humira Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Humira Distributors
  10. 12.2.3 Humira Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst